Recognized standard

F2119-07 (Reapproved 2013)

FDA recognition 8-153 · ASTM · Materials

Key facts

Recognition number 8-153
Designation F2119-07 (Reapproved 2013)
Title Standard Test Method for Evaluation of MR Image Artifacts from Passive Implants
Standards developer ASTM International
Specialty area Materials
Date of entry Aug 6, 2013
Scope (excerpt) 1.1 This test method characterizes the distortion and signal loss artifacts produced in a magnetic resonance (MR) image by a passive implant (implant that functions without the supply of electrical or external power). Anything not established to be MR-Safe or MR-Conditional is excluded.

At a glance

  • None Product codes
  • 1–9 FDA guidance documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA-recognized consensus standards

The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.

Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date:

Browse all FDA-recognized consensus standards